Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Peter Behner currently holds 20,115 shares of MiNK Therapeutics, Inc. (INKT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Peter Behner has been a net neutral trader of INKT stock. They have purchased $0 and sold $0 worth of shares.
Peter Behner's most recent insider trade was on Dec 1, 2025, when they sold 1,466 shares at $11.09 per share.
Peter Behner serves as Executive at MiNK Therapeutics, Inc. (INKT). They have executed 11 insider transactions totaling $0 over their tenure at the company.
Peter Behner holds the position of Executive at MiNK Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Peter Behner has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Peter Behner was on Sep 15, 2022, when they purchased $30.8K worth of INKT shares. This transaction involved 11,737 shares at $2.62 per share.
Peter Behner currently owns 20,115 shares of MiNK Therapeutics, Inc. (INKT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Peter Behner's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Peter Behner has 11 Form 4 filings on record as an insider at MiNK Therapeutics, Inc..
Set alerts for Peter Behner and 40,000+ other insiders.